Bogart Wealth’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
Other funds holding BIO
Bogart Wealth's BIO Position: Q3 2026 in Review
Bogart Wealth held its Bio-Rad Laboratories Class A (BIO) position steady in Q3 2026 at 16 shares worth $6.04K. The position accounts for ﹤0.01% of the portfolio, ranked #1172.
Bogart Wealth first reported a position in BIO in Q1 2022 and has held it in 9 quarters since. The position peaked at $7K in Q2 2022. 419 funds tracked by Wall St. Rank hold BIO as of Q3 2026.
- Bogart Wealth held 16 shares of Bio-Rad Laboratories Class A worth $6.04K as of Q3 2026.
- Bogart Wealth left its Bio-Rad Laboratories Class A share count unchanged in Q3 2026.
- Bio-Rad Laboratories Class A made up ﹤0.01% of Bogart Wealth's portfolio in Q3 2026, its #1172 holding.
- Bogart Wealth first reported a position in Bio-Rad Laboratories Class A in Q1 2022 and has held it in 9 quarters since.
- Bogart Wealth's Bio-Rad Laboratories Class A position peaked at $7K in Q2 2022.
- 419 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2026.
Based on Bogart Wealth's 13F filing for Q3 2026, filed 10 Nov 2026.